Must Asset Management Questions PharmaResearch's Rationale for Spin-Off, Seeks Clarity on Governance Benefits Over Non-Redundant Physical Split

Must Asset Management has publicly challenged PharmaResearch’s planned holding company spin-off, questioning its governance rationale and urging transparency on shareholder interests.